Serum RELT (soluble) was elevated in patients with gastric cancer and breast cancer [64, 65], especially in B-cell lymphomas, but RELT is an orphan receptor, and its ligand is unknown [66]. This evidence concerns the gene RELT and B-cell non-Hodgkin lymphoma.